Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, One Gustave Levy Place, New York, NY, 10029 USA.
Cardiol Clin. 2010 Feb;28(1):169-84. doi: 10.1016/j.ccl.2009.09.007.
Several new-generation percutaneous support devices are available or are in different stages of development for use in high-risk percutaneous coronary intervention (PCI), cardiogenic shock, and for other indications. Preliminary studies have demonstrated the feasibility and safety of these devices and the beneficial effect on hemodynamic parameters. In this article, the authors discuss (1) the percutaneous circulatory support devices presently available and routinely used in the catheterization laboratory, (2) the technical aspects involved with insertion and removal, and (3) relevant data from randomized trials, meta-analyses, and registries about the benefits of their use in patients with cardiogenic shock complicating ST segment elevation myocardial infarction and in those with significant left ventricular systolic dysfunction undergoing complex PCI.
几种新一代经皮支持设备可用于高危经皮冠状动脉介入治疗(PCI)、心源性休克和其他适应证,或处于不同的开发阶段。初步研究已经证明了这些设备的可行性和安全性,以及对血流动力学参数的有益影响。本文作者讨论了(1)目前在导管室中常规使用的经皮循环支持设备,(2)插入和移除涉及的技术方面,以及(3)关于这些设备在心源性休克合并 ST 段抬高型心肌梗死患者和接受复杂 PCI 的有明显左心室收缩功能障碍患者中的应用的随机试验、荟萃分析和登记研究的相关数据。